Science ❯ Biotechnology ❯ Pharmaceuticals
Product Development Immunotherapy mRNA Technology Drug Development Neuroreparative Therapies Veterinary Clinical Trials Cancer Treatments
The financing is intended to support clinical work on NVG-291 and company operations using proceeds from a U.S. and Canadian shelf offering.
